{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T08:12:54Z","timestamp":1763885574706,"version":"3.45.0"},"reference-count":24,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[2025,11]]},"abstract":"\n BACKGROUND:<\/jats:title>\n The coronavirus disease 2019 (COVID-19) pandemic disrupted cancer care, resulting in significant diagnostic delays.<\/jats:p>\n <\/jats:sec>\n \n OBJECTIVES:<\/jats:title>\n While prior studies have examined shifts in clinical stage, limited data exist on the pandemic's effect on histopathological features and long-term survival in gastric cancer (GC). We aimed to address this gap through a comprehensive comparative analysis.<\/jats:p>\n <\/jats:sec>\n \n DESIGN:<\/jats:title>\n Retrospective cohort study<\/jats:p>\n <\/jats:sec>\n \n SETTING:<\/jats:title>\n Tertiary-care center<\/jats:p>\n <\/jats:sec>\n \n PATIENTS AND METHODS:<\/jats:title>\n This single-center study included 317 participants newly diagnosed with GC, divided into pre-pandemic (March 2018\u2013March 2020) and pandemic (March 2020\u2013March 2022) groups. Demographic, clinical, and detailed histopathological characteristics and 1- and 3-year overall survival (OS) rates were compared between groups.<\/jats:p>\n <\/jats:sec>\n \n MAIN OUTCOME MEASURES:<\/jats:title>\n Comparison of clinical stage, treatment modality, histopathological features, and 1- and 3-year overall survival between GC patients diagnosed before and during the COVID-19 pandemic.<\/jats:p>\n <\/jats:sec>\n \n SAMPLE SIZE:<\/jats:title>\n 317 patients<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n \n The pandemic group exhibited a significantly higher rate of metastasis at diagnosis (38.0% vs. 26.9%;\n P<\/jats:italic>\n =.035), lower rate of surgical resection (54.0% vs. 65.3%;\n P<\/jats:italic>\n =.041), and higher rate of palliative therapy (44.0% vs. 31.1%;\n P<\/jats:italic>\n =.018). Histopathologically, this cohort had a greater proportion of high-grade (G3) tumors (\n P<\/jats:italic>\n =.014), lower median number of dissected lymph nodes (\n P<\/jats:italic>\n =.002), and poorer response to neoadjuvant therapy (\n P<\/jats:italic>\n =.025). Both 1- and 3-year OS were significantly lower in the pandemic group (\n P<\/jats:italic>\n =.009 and .045, respectively).\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n The COVID-19 pandemic was associated with more advanced disease at diagnosis and significantly worse long-term survival for patients with GC. These outcomes appear to result from diagnostic and treatment delays rather than substantial changes in tumor biology. These findings underscore the need to establish resilient cancer care systems to reduce vulnerability during health crises.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS:<\/jats:title>\n Single-center retrospective design and selection bias due to histopathological analyses being limited to surgically treated patients.<\/jats:p>\n <\/jats:sec>","DOI":"10.5144\/0256-4947.2025.388","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T08:09:23Z","timestamp":1763885363000},"page":"388-394","source":"Crossref","is-referenced-by-count":0,"title":["Influence of the coronavirus disease 2019 pandemic on gastric cancer: associations with diagnostic delays, clinicopathological features, and 3-year survival"],"prefix":"10.5144","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4608-1016","authenticated-orcid":true,"given":"Enver","family":"Yar\u0131kkaya","sequence":"first","affiliation":[{"name":"From the Department of Pathology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merve","family":"Cin","sequence":"additional","affiliation":[{"name":"From the Department of Pathology, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"issue":"1","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1186\/s12885-023-11441-w","article-title":"Short-term and long-term outcomes of patients with gastric cancer during versus before the COVID-19 pandemic: cohort study using propensity score matching method","volume":"23","author":"Sun Y","year":"2023","unstructured":"Sun Y, Chen C, Hou L, Zhao E. Short-term and long-term outcomes of patients with gastric cancer during versus before the COVID-19 pandemic: cohort study using propensity score matching method. BMC Cancer. 2023;23(1):913.","journal-title":"BMC Cancer"},{"issue":"5","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s10147-022-02142-8","article-title":"Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan","volume":"27","author":"Fujita S","year":"2022","unstructured":"Fujita S, Sakuramoto S, Miyawaki Y, Morimoto Y, Ebara G, Nishibeppu K, et al. Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan. Int J Clin Oncol. 2022;27(5):930\u20139.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5230\/jgc.2025.25.e10","article-title":"A comprehensive and comparative review of global gastric cancer treatment guidelines: 2024 update","volume":"25","author":"Eom SS","year":"2025","unstructured":"Eom SS, Ryu KW, Han HS, Kong SH. A comprehensive and comparative review of global gastric cancer treatment guidelines: 2024 update. J Gastric Cancer. 2025;25(1):153\u201376.","journal-title":"J Gastric Cancer"},{"issue":"8","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/diagnostics15080950","article-title":"Delayed diagnosis and evolving trends in gastric cancer during and after COVID-19: A comparative study of staging, Helicobacter pylori infection and bleeding risk in Western Romania","volume":"15","author":"Serena P","year":"2025","unstructured":"Serena P, Miutescu B, Gadour E, Burciu C, Mare R, Bende R, et al. Delayed diagnosis and evolving trends in gastric cancer during and after COVID-19: A comparative study of staging, Helicobacter pylori infection and bleeding risk in Western Romania. Diagnostics (Basel). 2025;15(8):950.","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3892\/etm.2024.12787","article-title":"An approach to COVID-19 and oncology: from impact, staging and management to vaccine outcomes in cancer patients: A systematic review and meta-analysis","volume":"29","author":"Ahmed RA","year":"2025","unstructured":"Ahmed RA, Aldalbahi AA, Alhumaidan NI, Alotaibi TA, Alharbi MA, Alharbi MA, et al. An approach to COVID-19 and oncology: from impact, staging and management to vaccine outcomes in cancer patients: A systematic review and meta-analysis. Exp Ther Med. 2025;29(2):37.","journal-title":"Exp Ther Med"},{"issue":"4","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s12029-021-00751-6","article-title":"Gastric cancer surgery during the pandemic: what it costs?","volume":"53","author":"Yazici H","year":"2022","unstructured":"Yazici H, Eren A, Uprak TK, Sahan C, Esmer AC, Yegen SC. Gastric cancer surgery during the pandemic: what it costs? J Gastrointest Cancer. 2022;53(4):848\u201353.","journal-title":"J Gastrointest Cancer"},{"issue":"10229","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(20)30553-5","article-title":"Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries","volume":"395","author":"Kandel N","year":"2020","unstructured":"Kandel N, Chungong S, Omaar A, Xing J. Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. Lancet. 2020;395(10229):1047\u201353.","journal-title":"Lancet"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e3508","article-title":"Impact of COVID-19 pandemic on the surgical treatment of gastric cancer","volume":"76","author":"Arneiro AJ","year":"2021","unstructured":"Arneiro AJ, Ramos MFKP, Pereira MA, Dias AR, Zilberstein B, Ribeiro Junior U, et al. Impact of COVID-19 pandemic on the surgical treatment of gastric cancer. Clinics (Sao Paulo). 2021;76:e3508.","journal-title":"Clinics (Sao Paulo)"},{"issue":"4","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/bjs\/znad003","article-title":"Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study","volume":"110","author":"Baxter MA","year":"2023","unstructured":"Baxter MA, Khan KS, Gall LS, Samuelson C, McCollum C, Chuntamongkol R, et al. Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study. Br J Surg. 2023;110(4):456\u201361.","journal-title":"Br J Surg"},{"issue":"7","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3390\/healthcare13070805","article-title":"Impact of the COVID-19 pandemic on gut cancer admissions and management: A comparative study of two pandemic years to a similar pre-pandemic period","volume":"13","author":"Cazacu SM","year":"2025","unstructured":"Cazacu SM, Rogoveanu I, Turcu-Stiolica A, Vieru AM, Gabroveanu A, Popa P, et al. Impact of the COVID-19 pandemic on gut cancer admissions and management: A comparative study of two pandemic years to a similar pre-pandemic period. Healthcare (Basel). 2025;13(7):805.","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/j.gastro.2020.05.037","article-title":"Impacts of the coronavirus 2019 pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: A population-based study","volume":"159","author":"Lui TKL","year":"2020","unstructured":"Lui TKL, Leung K, Guo CG, Tsui VWM, Wu JT, Leung WK. Impacts of the coronavirus 2019 pandemic on gastrointestinal endoscopy volume and diagnosis of gastric and colorectal cancers: A population-based study. Gastroenterology. 2020;159(3):1164\u20131166.e3.","journal-title":"Gastroenterology"},{"key":"e_1_3_2_13_2","first-page":"203","volume-title":"AJCC cancer staging manual","author":"Jessup MJ","year":"2017","unstructured":"Jessup MJ, Goldberg RM, Asare EA, Benson AIB, Brierly JD. Stomach. In: Amin MB, Greene FL, Edge SB, editors. AJCC cancer staging manual. 8th ed., corrected at 3rd printing. New York, New York: Springer; 2017. p. 203\u201320.","edition":"8"},{"issue":"10","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick F","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320.","journal-title":"Ann Oncol"},{"issue":"2","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani JA","year":"2022","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Canc Netw"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Mouni O Idrissi A Bouziane M Ahid S Sair K. Impact of the COVID-19 pandemic on digestive cancer staging a case series. Ann Med Surg (Lond). 2022;82. Available from: https:\/\/journals.lww.com\/10.1016\/j.amsu.2022.104471:104471.","DOI":"10.1016\/j.amsu.2022.104471"},{"issue":"2","key":"e_1_3_2_17_2","first-page":"194","article-title":"Impact of the Covid pandemic on timely cancer diagnosis across European healthcare settings: a scoping review","volume":"36","author":"Pennisi F","year":"2024","unstructured":"Pennisi F, Odelli S, Borlini S, Morani F, Signorelli C, Renzi C. Impact of the Covid pandemic on timely cancer diagnosis across European healthcare settings: a scoping review. Ann Ig. 2024;36(2):194\u2013214.","journal-title":"Ann Ig"},{"issue":"3","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"250","DOI":"10.28982\/josam.1072900","article-title":"Gastric cancer during COVID-19 pandemic: what changed?","volume":"6","author":"\u00d6zdemir Y","year":"2022","unstructured":"\u00d6zdemir Y, Baykan AR. Gastric cancer during COVID-19 pandemic: what changed? J Surg Med. 2022;6(3):250\u20133.","journal-title":"J Surg Med"},{"issue":"4","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/hcs2.57","article-title":"COVID-19 retreats and world recovers: A silver lining in the dark cloud","volume":"2","author":"Bisen AC","year":"2023","unstructured":"Bisen AC, Agrawal S, Sanap SN, Ravi Kumar HG, Kumar N, Gupta R, et al. COVID-19 retreats and world recovers: A silver lining in the dark cloud. Health Care Sci. 2023;2(4):264\u201385.","journal-title":"Health Care Sci"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85679","article-title":"An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs","volume":"12","author":"Muka T","year":"2023","unstructured":"Muka T, Li JJX, Farahani SJ, Ioannidis JPA. An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs. eLife. 2023;12:e85679.","journal-title":"eLife"},{"issue":"2","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00595-021-02329-y","article-title":"Impact of COVID-19 on gastric cancer treatment in Japanese high-volume centers: a JCOG stomach cancer study group survey","volume":"52","author":"Tokunaga M","year":"2022","unstructured":"Tokunaga M, Yoshikawa T, Boku N, Nishida Y, Tanahashi T, Yamada T, et al. Impact of COVID-19 on gastric cancer treatment in Japanese high-volume centers: a JCOG stomach cancer study group survey. Surg Today. 2022;52(2):231\u20138.","journal-title":"Surg Today"},{"issue":"9","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3349\/ymj.2023.0074","article-title":"Impact of the COVID-19 pandemic on esophagogastroduodenoscopy and gastric cancer claims in South Korea: A nationwide, population-based study","volume":"64","author":"Suh MA","year":"2023","unstructured":"Suh MA, Park SB, Kwak MS, Yoon JY, Cha JM. Impact of the COVID-19 pandemic on esophagogastroduodenoscopy and gastric cancer claims in South Korea: A nationwide, population-based study. Yonsei Med J. 2023;64(9):549\u201357.","journal-title":"Yonsei Med J"},{"issue":"12","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00595-022-02501-y","article-title":"Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemic","volume":"52","author":"Saeki H","year":"2022","unstructured":"Saeki H, Shirabe K, Miyazaki T, Ogawa T, Makita F, Shitara Y, et al. Decreased numbers of gastric, colorectal, lung, and breast cancer surgeries performed in 17 cancer-designated hospitals in Gunma Prefecture of Japan during the COVID-19 pandemic. Surg Today. 2022;52(12):1714\u201320.","journal-title":"Surg Today"},{"issue":"1","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/03008916211072586","article-title":"Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy","volume":"109","author":"Solaini L","year":"2023","unstructured":"Solaini L, Bencivenga M, Rosa F, D'ignazio A, Marino E, Ministrini S, et al. Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy. Tumori. 2023;109(1):121\u20138.","journal-title":"Tumori"},{"issue":"23","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"35084","DOI":"10.18632\/oncotarget.9041","article-title":"Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy","volume":"7","author":"Shi RL","year":"2016","unstructured":"Shi RL, Chen Q, Ding JB, Yang Z, Pan G, Jiang D, et al. Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy. Oncotarget. 2016;7(23):35084\u201391.","journal-title":"Oncotarget"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T08:09:44Z","timestamp":1763885384000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2025.388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.5144\/0256-4947.2025.388"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2025.388","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}